Clinical studies with gastric inhibitory polypeptide
- 1 September 1979
- journal article
- research article
- Published by Wiley in World Journal of Surgery
- Vol. 3 (5) , 553-557
- https://doi.org/10.1007/bf01654758
Abstract
Intravenous infusion of porcine GIP in man induces insulin release when a degree of hyperglycemia is present. This glucose-dependent insulinotropic response occurs when a dose of GIP is administered to obtain circulating levels of approximately 1 ng/ml, a physiologic level that can be achieved by the ingestion of glucose or corn oil or a mixed meal. Serum GIP was measured by radioimmunoassay, and the single antiserum used in all the described studies measures 2 immunoreactive forms of GIP. In patients with chronic pancreatitis receiving an oral glucose load or a mixed liquid test meal, GIP levels have been shown to be exaggerated. Similar elevated responses have been observed in obese patients and in maturity onset diabetes. A reduced GIP response has been seen in patients with celiac disease. A physiologic role for GIP in the enteroinsular axis has been established. However, involvement of the hormone in pathophysiologic situations is equivocal. La perfusion intraveineuse chez l'homme de GIP de porc provoque une libération d'insuline lorsqu'un certain degré d'hypoglycémie est atteint. Cette riposte insulinique dépendant de la glycémie survient pour une dose de GIP donnant un taux circulant de ±1 ng/ml, soit un taux physiologique qui peut être atteint après ingestion de glucose, d'huile de maïs, ou d'un repas varié. Nous avons mesuré les taux sériques de GIP par radio-immunoessai; l'antisérum utilisé dans toute l'étude mesure 2 formes immunoréactives de GIP. Chez les malades atteints de pancréatite chronique, les taux de GIP sont anormalement élevés après glucose per os ou après un repas liquide à plusieurs composantes. Les mêmes types de réponses exagérées ont été observées chez les sujets obéses ou dans le diabète débutant de l'adulte. La réponse est inférieure à la normale en cas de malade coeliaque. Le GIP a sans aucun doute une action physiologique sur l'axe entéro-insulaire. Mais son rôle dans les états pathologiques n'est pas encore clairement démontré.Keywords
This publication has 22 references indexed in Scilit:
- Gastric inhibitory polypeptide (GIP) and insulin in obesity: Increased response to stimulation and defective feedback control of serum levelsDiabetologia, 1978
- Response of gastric inhibitory polypeptide (GIF) to test meal in chronic pancreatitis ? Relationship to endocrine and exocrine insufficiencyDiabetologia, 1976
- Gastric inhibitory polypeptide (GIP), gastrin and insulin: Response to test meal in coeliac disease and after duodeno-pancreatectomyDiabetologia, 1976
- Gastric Inhibitory Polypeptide: Its Physiologic Release and Insulinotropic Action in the DogDiabetes, 1975
- Cellular localization of gastric inhibitory polypeptide in the duodenum and jejunumGut, 1973
- DOSE-RESPONSE RELATION BETWEEN PLASMA-INSULIN AND BLOOD-GLUCOSE LEVELS DURING ORAL GLUCOSE LOADS IN PREDIABETIC AND DIABETIC SUBJECTSThe Lancet, 1973
- A Gastric Inhibitory Polypeptide. I. The Amino Acid Composition and the Tryptic PeptidesCanadian Journal of Biochemistry, 1971
- Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*Journal of Clinical Investigation, 1967
- Insulin Secretion in ObesityNew England Journal of Medicine, 1967
- FOREARM METABOLISM IN OBESITY AND ITS RESPONSE TO INTRA-ARTERIAL INSULIN. CHARACTERIZATION OF INSULIN RESISTANCE AND EVIDENCE FOR ADAPTIVE HYPERINSULINISM*Journal of Clinical Investigation, 1962